Jazz Pharmaceuticals Public Limited Company (JAZZ)

124.65
3.10 2.60
NASDAQ
Prev Close 121.51
Open 122.58
Day Low/High 122.05 / 125.20
52 Wk Low/High 117.64 / 189.00
Volume 198.65K
Exchange NASDAQ
Shares Outstanding 61.47B
Market Cap 7.39B
P/E Ratio 53.37
Div & Yield N.A. (N.A)
A Trio of Breakouts

A Trio of Breakouts

Jazz Pharma, Qihoo and Rite-Aid are all on fire today.

Biotech Remains on Fast Track

Biotech Remains on Fast Track

Even after a run, some stocks still offer growth.

Going Solar

Going Solar

The group's been leading and it should continue to perform in 2014.

The Action Is High

The Action Is High

But trust in this market is low.

Music to My Ears

Music to My Ears

Here's why I like a lower opening.

Meet the New 'Four Horsemen'

Meet the New 'Four Horsemen'

Catch them if you can.

Jazz increases price target at UBS

Rules of the Game: Investment Philosophy

Rules of the Game: Investment Philosophy

Think of how investments will help you in the future.

Jazz numbers raised at UBS

Jazz numbers raised at UBS

Earnings Roundup

Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...

A Health Care Trio in Rally Mode

A Health Care Trio in Rally Mode

Jazz Pharmaceuticals, Parexel and HCA have made recent upside moves in heavy volume.

Healthy Retracements Refuel Bull Run

Healthy Retracements Refuel Bull Run

Brittany Umar and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.

Two Biopharmaceutical Growth Stars

Two Biopharmaceutical Growth Stars

Jazz and Questcor offer investors reasonable valuations in this area.

JAZZ in Thirds

While the stock is still drifting lower, it is doing so on lighter volume, so I'll cover one-third of my short. Jazz Pharmaceuticals (JAZZ) continues to trade poorly after forming a head-and-shoulders pattern. I wrote about this in my April 13 colum...

JAZZ Plays a Sour Note

JAZZ Plays a Sour Note

I wouldn't be surprised to see JAZZ lose another 10% from here before finding support.

Jazz Pharma numbers raised at Jefferies

Trading in an Extended Market

Trading in an Extended Market

I'm flipping into strength and continuing to look for pockets of momentum.

Sticking With Long Plays

Sticking With Long Plays

I'm not seeing any real weakness yet to justify a short.

Keep Digging for Opportunities

Keep Digging for Opportunities

The dip-buying is good but we need to see stronger momentum and better leadership.

A Gap Up and Fade

A Gap Up and Fade

The action is strong, but the market isn't gaining additional traction.